INTERNATIONAL PATENT: EXELIXIS, INC. FILES APPLICATION FOR "INTERLEUKIN-13 RECEPTOR SUBUNIT ALPHA-2 ANTIBODY-DRUG CONJUGATES AND USES THEREOF"

GENEVA, Jan. 29 -- EXELIXIS, INC. (1851 Harbor Bay ParkwayAlameda, CA 94502) filed a patent application (PCT/US2024/038754) for "INTERLEUKIN-13 RECEPTOR SUBUNIT ALPHA-2 ANTIBODY-DRUG CONJUGATES AND USES THEREOF" on Jul 19, 2024. With publication no. WO/2025/019776, the details related to the patent application was published on Jan 23, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DRAKE, Penelope, M. (c/o Exelixis, Inc.1851 Harbor Bay ParkwayAlameda, CA 94502), KANTAK, Seema (c/o Exelixis, Inc.1851 Harbor Bay ParkwayAlameda, CA 94502), MENDELSOHN, Brian, Alan (c/o Exelixis, Inc.1851 Harbor ...